RETINAL DYSTROPHY

Clinical trials for RETINAL DYSTROPHY explained in plain language.

Never miss a new study

Get alerted when new RETINAL DYSTROPHY trials appear

Sign up with your email to follow new studies for RETINAL DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2 Completed 1

Gene therapy hope for kids and adults with rare Blindness-Causing mutation

Disease control Recruiting now

This early-phase study tests a gene therapy called LX107 for people with a rare inherited eye disease caused by mutations in the AIPL1 gene. The treatment is given as an injection under the retina to try to improve vision and slow disease progression. The study will include 13 ad…

Matched conditions: RETINAL DYSTROPHY

Phase: EARLY_PHASE1 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control

Last updated Jun 27, 2026 11:00 UTC

RETINAL DYSTROPHY

Get alerted when new RETINAL DYSTROPHY trials appear

Gene therapy hope for kids and adults with rare Blindness-Causing mutation